The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey

Saudi Medical Journal

Volumn 29, Issue 10, 2008, Pages 1480-1483

  Al Qurashi, Mansour M ^a   El Mouzan, Mohammad I ^a   Al Herbish, Abdullah S ^a   Al Salloum, Abdullah A ^a   Al Omar, Ahmad A ^b  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b Children's Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; COMMUNITY SAMPLE; CROSS-SECTIONAL STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PREVALENCE; RANDOM SAMPLE; SAUDI ARABIA; SEX RATIO; SICKLE CELL ANEMIA; CLINICAL TRIAL; DEMOGRAPHY; MULTICENTER STUDY; PRESCHOOL CHILD;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PREVALENCE; RESIDENCE CHARACTERISTICS; SAUDI ARABIA;

EID: 58749115738     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nasserullah Z, Al-Jame A, Abu Srair H, Al Qatari G, Al Naim S, Al-Aqib A, et al. Neonatal screening for sickle cell disease, Glucose-6-phosphate dehydrogenase deficiency and beta-thalassemia in QATIF and AL HASA. Ann Saudi Med 1998; 18: 289-292.
2. el Mouzan MI, al Awamy BH, al Torki MT. Clinical features of sickle cell disease in eastern Saudi Arab children. Am J Pediatr Hematol Oncol 1990; 12: 51-55.
3. al-Nuaim L, Talib ZA, el-Hazmi MA, Warsy AS. Sickle cell and G-6-PD deficiency gene in cord blood samples: Experience at King Khalid University Hospital, Riyadh. J Trop Pediatr 1997; 43: 71-74.
4. Nietert PJ, Silverstein MD, Abhoud MR. Sickle cell anaemia: Epidemiology and cost of illness. Pharmacoeconomics 2002; 20 357-366. Erratum in: Pharmacoeconomics 2002; 20: 853.
5. Karnon J, Zeuner D, Ades AE, Efimba W, Brown J, Yardumian A. The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: A modelling approach. J Public Health Med 2000; 22: 500-511.
6. El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Qurachi MM, Al-Omar AA. Growth charts for Saudi children and adolescents. Saudi Med J 2007; 28: 1555-1568.
7. el-Hazmi MA, Warsy AS, al-Swailem AR, al-Swailem AM, Bahakim HM. Sickle cell gene in the population of Saudi Arabia. Genet Med 1996; 20: 187-198.
8. Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007; 9: 372-377.
9. El-Hazmi AF, Warsy AS. Hemoglobinopathies in Arab countries. In: Teebi AS, Farag TI, editors. Genetic disorders among Arab populations. Oxford monographs on medical genetics. No. 30. New York: Oxford University Press, 1999. p. 83-110.
10. Al-Arrayed S, Suleiman AJ, Afifi M, Al-Lamki ZM, Daar S. A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J 2001; 7: 1004-1011.
11. Al-Arrayed S, Hafadh N, Amin S, A-Mukhareq H, Sanad H. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 2003; 9: 344-352.
12. Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: Burden and research priorities. Ann Trop Med Parasitol 2007; 101: 3-14.
13. Diallo D, Tchernia G. Sickle cell disease in Africa. Curr Opin Hematol 2002; 9: 111-116.
14. US Preventive Services Task Force. Screening for sickle cell disease in newborns: Recommendation statement. Ann Fam Physician 2002; 77: 1300-1302.
15. Driscoll MC. Sickle cell disease. Pediatr Rev 2007; 28: 259-268.
16. Hickman M, Modell B, Greengross P, Chapman C, Layton M, Falconer S, et al. Mapping the prevalence or sickle cell and beta thalassaemia in England: Estimating and validating ethnic-specific rates. Br J Haematol 1999; 104: 860-867.
17. Davis H, Schoendorf KC, Gergen PJ, Moore RM Jr. National trends in the mortality of children with sickle cell disease, 1968 through 1992. Am J Public Health 1997; 87: 1317-1322.